Abstract
The use of biological valves as a substitute for the diseased heart valve is not a new concept and indeed goes back to 19 62 when we inserted the first aortic valve homograft. Since that time, although mechanical valves of one type or another have been in continuous use, homo-grafts have been confined to two or three centres and it is only over the past 5–7 Years that there has been a resurgence of interest in the biological valve principle. This has chiefly been brought about by Hancocks’s foresight in commercializing the product, fixing the valve to a frame for ease of insertion, and making it readily available.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Carpentier A (1969) Evolution of concepts and techniques of valvular heterografts. Ann Surg [Supp1] 172:1
Zerbini EJ, Puig LB (1979) Experience with dura mater allograft. Long term results. In: Sebening F, Klovekorn WP, Meisner H, Struck E (eds) Bioprosthetic cardiac valves. Deutsches Herzzentrum Munich, p 179
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ross, D.N. (1981). Invited Lecture Biological Valves in Cardiac Surgery. In: Bircks, W., Ostermeyer, J., Schulte, H.D. (eds) Cardiovascular Surgery 1980. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68172-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-68172-1_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68174-5
Online ISBN: 978-3-642-68172-1
eBook Packages: Springer Book Archive